DES MOINES, Iowa - An Iowa state appeals court on April 24 said that the U.S. Supreme Court's generic drug preemption ruling does not allow a claim against a metoclopramide manufacturer for failing to update its label and that the plaintiff failed to preserve her claims against the makers of Reglan, the brand-name version of the drug (Theresa Huck v. Trimark Physicians Group, et al., No. 3-129/12-0596, Iowa App.; 2013 Iowa App. LEXIS 435)....(read more)Image may be NSFW.
Clik here to view.
Clik here to view.
